Almuth Steinkühler has been CFO of SCHOTT Pharma, which designs drug containment products and drug delivery systems for pharmaceutical and biotech companies, since August 2022. Originally a division of glass manufacturer Schott AG, the company went public on the Frankfurt Stock Exchange in 2023. Steinkühler previously worked at ThyssenKrupp and Continental AG. Global Finance: What has been the biggest challenge of your tenure as financial head of SCHOTT Pharma, given its new status as a public